Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1

Genes and Development

Volumn 15, Issue 3, 2001, Pages 328-339

  Richard, Derek J ^a   Schumacher, Valérie ^b   Royer Pokora, Brigitte ^b   Roberts, Stefan G E ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Coactivator; Par4; Transcription; WT1

Indexed keywords

AMINO ACID; PROTEIN PAR4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR WT1; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE ACTIVATION; GENE DISRUPTION; GENE FUNCTION; GENE INSERTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; APOPTOSIS; CELLS, CULTURED; DNA-BINDING PROTEINS; HELA CELLS; HUMANS; PROTEIN CONFORMATION; PROTEIN ISOFORMS; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; WT1 PROTEINS;

MAMMALIA;

EID: 0035252110     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.185901     Document Type: Article

References (53)

1. Mutation analysis of the WT1 gene in sporadic childhood leukaemia
2. Interaction of human thyroid hormone receptor b with transcription factor TFIIB can mediate target gene derepression and activation by thyroid hormone
3. Donor splice-site mutations in WT1 are responsible for Frasier syndrome
4. RNA binding by the Wilms tumor suppressor zinc finger proteins
5. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1
6. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes
7. Multiple roles for the Wilms' tumor suppressor, WT1
8. Repression of the transforming growth-factor- β-1 gene by the Wilms-tumor suppressor WT1 gene-product
9. Constitutional WT1 mutations in Wilms' tumour patients
10. Repression of the insulin-like growth factor-II gene by the Wilms-tumor suppressor WT1
11. WT1 - More than a transcription factor?
12. WT1 suppresses synthesis of the epidermal growth-factor receptor and induces apoptosis
13. Induction of p21 by the Wilms' tumor suppressor gene WT1
14. Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control
15. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1
16. The role of human TFIIB in transcription start site selection in vitro and in vivo
17. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors
18. Software and database for the analysis of mutations in the human WT1 gene
19. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1
20. Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1
21. The evolution of WT1 sequence and expression pattern in the vertebrates
22. Wilms' tumour (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance
23. WT-1 is required for early kidney development
24. Presence of WT1, the Wilms' tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein
25. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing
26. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-messenger RNA splicing
27. The Wilms' tumor suppressor WT1 encodes a transcriptional activator of amphiregulin
28. Mechanism of action of an acidic transcriptional activator in vitro
29. Binding of general transcription factor TFIIB to an acidic activating region
30. WT1: What has the last decade told us?
31. Transcriptional repression mediated by the WT1 Wilms tumor gene product
32. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells
33. Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70
34. Stimulation of E2F1/DP1 transcriptional activity by Mdm2 oncoprotein
35. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene
36. Regulation of the Wilms' tumour suppressor protein transcriptional activation domain
37. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor
38. Transactivation of the WT1 antisense promoter is unique to the WT1[+/-] isoform
39. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells
40. The Wilms tumour gene WT1 in leukaemia
41. Apoptosis mediated by a novel leucine zipper protein Par-4
42. The WT1 Wilms' tumor suppressor gene: How much do we really know?
43. The Wilms-tumor (WT1) gene-product both activates and represses transcription
44. WT1-mediated transcriptional activation is inhibited by dominant-negative mutant proteins
45. Overproduction and single-step purification of Gal4 fusion proteins from Escherichia coli
46. Differential splicing of exon 5 of the Wilms tumour (WT1) gene
47. Mechanisms of transcriptional activation and repression
48. Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology
49. Analysis of WT1 target gene expression in stably transfected cell lines
50. The Wilms tumor gene product, WT1, represses transcription of the platelet-derived growth-factor A-chain gene
51. The Wilms tumor gene product WT1 activates or suppresses transcription through separate functional domains
52. Products of alternatively spliced transcripts of the Wilms tumor suppressor gene, WT1, have altered DNA-binding specificity and regulate transcription in different ways
53. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300